We report, for the first time, that rfhSP-D interacts with HA that negates its anti-tumor properties; i.e., in the presence of HA, rfhSP-D is unable to induce apoptosis in triple-positive and HER2-overexpressing breast cancer cell lines. The gene discussed is ERBB2; the disease is breast carcinoma.